Company profile

Ticker
HUM
Exchange
Website
CEO
Bruce Dale Broussard
Employees
Incorporated in
Location
Fiscal year end
SEC CIK
IRS number
610647538

HUM stock data

(
)
FINRA relative short interest over last month (20 trading days) ?

Calendar

20 Feb 20
4 Apr 20
31 Dec 20

News

Company financial data Financial data

Quarter (USD) Dec 19 Sep 19 Jun 19 Mar 19
Revenue 16.3B 16.24B 16.25B 16.11B
Net income 512M 689M 940M 566M
Diluted EPS 3.84 5.14 6.94 4.16
Net profit margin 3.14% 4.24% 5.79% 3.51%
Operating income 362M 868M 1.12B 847M
Net change in cash -1.47B 749M 901M 1.53B
Cash on hand 4.05B 5.53B 4.78B 3.88B
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue 64.89B 56.91B 53.77B 54.38B
Net income 2.71B 1.68B 2.45B 614M
Diluted EPS 20.1 12.16 16.81 4.07
Net profit margin 4.17% 2.96% 4.55% 1.13%
Operating income 3.19B 3.1B 4.26B 1.74B
Net change in cash 1.71B -1.7B 165M 1.31B
Cash on hand 4.05B 2.34B 4.04B 3.88B

Financial data from Humana earnings reports

Date Owner Security Transaction Code $Price #Shares $Value #Remaining
31 Mar 20 Karen Katz RSU Humana Common Grant Aquire A 308.215 86 26.51K 86
31 Mar 20 McDonald William J. RSU Humana Common Grant Aquire A 308.215 86 26.51K 10,250
31 Mar 20 Hilzinger Kurt J RSU Humana Common Grant Aquire A 308.215 239 73.66K 9,809
26 Mar 20 Wheatley Timothy Alan Phantom Stock Units Humana Common Other Aquire J 304.48 10 3.04K 138
26 Mar 20 Zipperle Cynthia H Phantom Stock Units Humana Common Other Aquire J 304.48 11 3.35K 280
94.1% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 786 731 +7.5%
Opened positions 143 99 +44.4%
Closed positions 88 76 +15.8%
Increased positions 231 260 -11.2%
Reduced positions 309 259 +19.3%
13F shares
Current Prev Q Change
Total value 368.79B 230.81B +59.8%
Total shares 124.32M 125.29M -0.8%
Total puts 1.69M 2.07M -18.4%
Total calls 1.26M 1.08M +17.1%
Total put/call ratio 1.3 1.9 -30.3%
Largest owners
Shares Value Change
BLK BlackRock 12.11M $4.44B -2.1%
Vanguard 10.19M $3.74B -1.1%
Capital International Investors 10.04M $3.68B +0.0%
Capital Research Global Investors 7.83M $2.87B +15.2%
FMR 6.23M $2.28B -2.4%
STT State Street 5.78M $2.12B -0.7%
Capital World Investors 5.19M $1.9B +3.4%
Renaissance Technologies 2.95M $1.08B -0.2%
Wellington Management 2.44M $895.67M -15.9%
N Price T Rowe Associates 1.9M $697.86M +85.6%
Largest transactions
Shares Bought/sold Change
GQG Partners 1.14K -2.51M -100.0%
Norges Bank 1.3M +1.3M NEW
Capital Research Global Investors 7.83M +1.03M +15.2%
N Price T Rowe Associates 1.9M +878.03K +85.6%
Aqr Capital Management 1.17M +841.3K +257.4%
Ceredex Value Advisors 554.63K -581.8K -51.2%
Glenview Capital Management 1.06M -539.68K -33.7%
Millennium Management 179.73K -518.18K -74.2%
GS The Goldman Sachs Group, Inc. 1.56M +481.22K +44.7%
Wellington Management 2.44M -461.3K -15.9%

Financial report summary

?
Risks
  • Risks Relating to Our Business
  • If we fail to effectively implement our operational and strategic initiatives, including our Medicare initiatives and our state-based contracts strategy, our business may be materially adversely affected, which is of particular importance given the concentration of our revenues in these products. In addition, there can be no assurances that we will be successful in maintaining or improving our Star ratings in future years.
  • If we fail to properly maintain the integrity of our data, to strategically implement new information systems, or to protect our proprietary rights to our systems, our business may be materially adversely affected.
  • If we are unable to defend our information technology security systems against cybersecurity attacks or prevent other privacy or data security incidents that result in security breaches that disrupt our operations or in the unintended dissemination of sensitive personal information or proprietary or confidential information, we could be exposed to significant regulatory fines or penalties, liability or reputational damage, or experience a material adverse effect on our results of operations, financial position, and cash flows.
  • We are involved in various legal actions and governmental and internal investigations, any of which, if resolved unfavorably to us, could result in substantial monetary damages or changes in our business practices. Increased litigation and negative publicity could increase our cost of doing business.
  • As a government contractor, we are exposed to risks that may materially adversely affect our business or our willingness or ability to participate in government health care programs.
  • Our business activities are subject to substantial government regulation. New laws or regulations, or legislative, judicial, or regulatory changes in existing laws or regulations or their manner of application could increase our cost of doing business and may have a material adverse effect on our results of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting our ability to expand into new markets, increasing our medical and operating costs by, among other things, requiring a minimum benefit ratio on insured products, lowering our Medicare payment rates and increasing our expenses associated with assessments); our financial position (including our ability to maintain the value of our goodwill); and our cash flows.
  • Any failure by us to manage acquisitions, divestitures and other significant transactions successfully may have a material adverse effect on our results of operations, financial position, and cash flows.
  • If we fail to develop and maintain satisfactory relationships with the providers of care to our members, our business may be adversely affected.
  • Our pharmacy business is highly competitive and subjects us to regulations in addition to those we face with our core health benefits businesses.
  • If we do not continue to earn and retain purchase discounts and volume rebates from pharmaceutical manufacturers at current levels, our gross margins may decline.
  • Our ability to obtain funds from certain of our licensed subsidiaries is restricted by state insurance regulations.
  • Downgrades in our debt ratings, should they occur, may adversely affect our business, results of operations, and financial condition.
  • The securities and credit markets may experience volatility and disruption, which may adversely affect our business.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: adapt, added, AIP, biographical, Boston, break, Brigham, Citibank, conclusion, Conviva, Cox, CVS, Diamond, Dollar, dominated, drawn, Enclara, episodically, ESRD, expedient, FinTech, forecasting, Harvard, Heather, incomplete, institution, jumbo, leasehold, manufacturing, MayYet, mission, Missouri, MMA, mobile, NaN, nonlease, nonpayment, NOPAT, OEP, opioid, oversaw, partnership, passion, PBM, Pittsburgh, Plansor, Professor, PubliclyAnnounced, PurchasedUnder, ran, reassessing, recontracting, reshaping, residual, revert, rollforward, ROU, School, Scientific, shift, short, Shrank, skill, smaller, SNP, stand, supply, Susan, telehealth, transformation, treating, University, USAA, Women, workday
Removed: announced, appeal, backed, Beveridge, Bilney, Bloomin, cardiology, collectibility, comparability, decided, deteriorated, deterioration, deviation, discontinuance, dividing, emerge, endocrinology, escrow, expended, experiment, fact, factoring, FEHBP, geriatric, heightened, imposing, LeClaire, limiting, locked, municipality, neurology, noted, ophthalmology, penetration, Penn, persistency, podiatry, prolonged, redeem, remit, robust, scalable, serviced, slightly, standalone, stipulating, summing, Transcend, transitioned, Treaty, unaffiliated, unlocked, Virginia, weekday, worth